United States: The Innovation Act Of 2015: Congress Targets Patent ‘Trolls’ Again

On February 5, 2015, the House Judiciary Chairman, Rep. Bob Goodlatte (R-VA), flanked by a bipartisan group of his peers, reintroduced his "Innovation Act" (H.R. 9). The bill is the second time in as many years that the Republican-controlled House has introduced legislation aimed at curtailing the excesses of patent protection litigation. In mid-2014, the first incarnation of the "Innovation Act" (H.R. 3309) passed the House but died in the Democratic-controlled Senate. This time, however, the Republican majority extends into the Senate.

In his statement, Rep. Goodlatte pitched the bill as "commonsense reform" aimed at "curb[ing] abusive patent litigation."1 The Act's major provisions include significantly heightened pleading and demand letter requirements, an attorney's fee shift to the non-prevailing party, discovery limits, plaintiff patent ownership transparency, and stays of litigation against end users. These reforms are aimed ostensibly at protecting emerging and innovative market enterprises. Rep. Darrell Issa (R-CA), another of the bill's supporters, explained that "increasingly, Americans find innovation obstructed, with attempts to enter the marketplace frequently shut down by well-funded patent trolls who exploit loopholes in the patent system." 2But if this is really the Act's intent, something may have gone awry. The companies lining up in support of the Innovation Act include Apple, Google, and Broadcom – not exactly average garage start-ups. Meanwhile, those who should be cheering legislation aimed at making it easier for start-ups to enter the marketplace are urging caution.

Six higher education associations, including the American Council on Education and the Association of American Universities, criticize the Act for debilitating the U.S. patent system and "discouraging the private sector from turning a university's research discoveries into the innovations that improve our nation's economy, health, and quality of life." 3Also, in a January 21 letter to the House Judiciary Committee, a host of 250 companies, start-ups, and known innovators — including Qualcomm Inc., Merck & Co., and Monsanto Co. — objected to the bill, claiming congressional action was unnecessary in the wake of legal measures that have reined in the worst patent litigation abuses. 4

Whether a GOP Senate will spell a different fate for the Innovation Act remains to be seen, but it is worth revisiting the major provisions in the proposed legislation.

Heightened Pleading Standard

The Innovation Act's changes to the pleading requirements for patent infringement actions are arguably its most sweeping. In brief, Section 3 of the Act would require patent holders to allege how each asserted claim under a given patent is found within each infringing process, product, or instrumentality. The Act attempts to balance these stiff requirements with the caveat that they are not required if the information is "not reasonably" or "readily" accessible (the Act uses both terms). 5Even if they are able to meet this standard, plaintiffs are still required to explain why the information was not accessible and to describe the efforts made to access it. The Act's rigorous requirements are intended to discourage unwarranted fishing expeditions by patent trolls, but the question remains as to whether they will effectively bar many valid infringement claims as an unintended consequence. Much will depend on how courts interpret not reasonably and readily accessible – terms which are undefined in the bill.

Loser-Pays Fee-Shifting

The first incarnation of the Innovation Act (H.R. 3309) caught the ire of then-Majority Leader Senator Harry Reid (D-NV). This was due to the Act replacing the bedrock presumption that parties bear their own costs, absent fraud or recklessness, with one where the non-prevailing party must pay the prevailing party's fees. This measure returns in Section 3 of the new Innovation Act (H.R. 9), but this time with a different majority leader, Mitch McConnell (R-KY). Regardless of which party controls the Senate, significant concerns remain as to the fee-shifting provision's potential effectiveness in combatting patent litigation abuses. The chief problem recognized by many commentators is that in order to have any real effect, defendants must "prevail" in court. Many accused infringers are often unwilling to take that risk, especially when settling early is still a relatively cheap alternative to litigation. This problem is accentuated because those who abuse the system generally bank on their opponents settling. Thus, they are willing to risk that an accused infringer would rather avoid a lengthy, costly patent dispute than waiting to see if they can prevail before the fact-finder. Nevertheless, the fee-shifting provision may embolden some companies that refuse to quickly settle with patent abusers and perhaps encourage others to follow suit.

Transparency in Patent Ownership

Section 4 of the Innovation Act demands transparency in patent ownership by requiring plaintiffs to disclose up front "the ultimate parent entity" of any assignee of the patent. 6This is aimed at the common practice whereby nonpracticing patent enforcers hide behind a web of shell companies when filing their suits. This duty, moreover, is ongoing throughout the course of the litigation. To give the provision teeth, the disclosure rules are imposed under threat of penalty, including increased damages under Section 285.

Limitations on Demand Letters

The Innovation Act also takes aim at "purposely evasive demand letters." Blanket demand letters are often the quintessential tool of the stereotypical patent troll and there is wide agreement that those letters need curtailing. The Innovation Act would amend Section 284 of the Patent Act to include a "Willful Infringement" section that requires identifying "with particularity": the asserted patent, product or process accused, the ultimate parent's entity, and how the product or process infringes a patent claim. American high-tech companies of all sizes, including start-ups, strongly favor this provision. Indeed, the Democrat-backed alternate, the STRONG Patent Act (S. 632), employs even harsher tactics across the board against trolls, including for "rogue and opaque letters" sent in "bad faith." 7But without knowing more about the distinction between what constitutes a "bad faith" letter, those in the legal community still are hesitant to praise such aggressive patent amendments.

Mandatory Stays of Action Against Consumers

The Innovation Act also provides that an action against a customer may be stayed if the customer agrees to be bound by the results of a suit against the manufacturer. 8This is designed to expand the currently available "customer suit exception," so that patent owners cannot sue a defendant's customers to pressure the defendant into settling. However, some view this provision as the most troubling of all. One healthcare public policy expert from the California Health Institute warns that this provision will "prolong litigation, increase costs, while placing a company's intellectual property in legal limbo." 9The Intellectual Property Owners (IPO) Association supports the provision, but agrees that carefully tailored language must be used to avoid adverse consequences to innovators.

Conclusion

While the Act has broad bipartisan support that likely will extend again to the White House, 10the bill's sponsors have not yet persuaded everyone that the Act is the proper tool for the job. The steady decline in patent litigation brought by nonpracticing entities since the enactment of the AIA begs the question whether the Innovation Act is necessary. 11Indeed, a study by Lex Machina found that patent litigation rates were declining steadily and last year were back to 2009 and 2010 levels. 12Perhaps to combat abusive litigation, a simpler, more targeted solution is preferable, or perhaps a little time and patience is needed to allow the AIA to do its job.

Footnotes

1 See Goodlatte Patent Reform Bill Reintroduced in U.S. House, Washington Examiner, Feb. 5, 2015, available at http://www.washingtonexaminer.com/goodlatte-patent-reform-bill-re-introduced-in-u.s.-house/article/feed/2175613.

2.Id.

3.See BIO and Universities Caution Against Innovation Act, BIOTech Now, Feb. 6, 2015, available at http://www.biotech-now.org/public-policy/patently-biotech/2015/02/bio-and-universities-caution-against-innovation-act-emphasize-the-need-for-patent-protection

4.See Patent Law Reform Bill to Stop Trolls Could Stifle Innovation, Washington Times, Feb. 5, 2015, Washington Times, available at http://www.washingtontimes.com/news/2015/feb/5/patent-law-reform-bill-to-stop-trolls-could-stifle/?page=all

5.H.R. 9 §§3(a)-(b).

6.H.R. 9 § 4.

7.U.S. Sens. Chris Coons (D-DE), Dick Durbin (D-IL) and Mazie Hirono (D-HI) introduced the "STRONG" Patents Act, or "Support Technology and Research for Our Nation's Growth" Patents Act. The STRONG Patent Act (S. 632) is considered overwhelmingly more pro-patentee than the H.R. 9 Innovation Act for reasons such as: it does away with the PTAB practice of interpreting claims based on the broadest reasonable interpretation; amends 35 U.S.C. 284 with respect to willful damages and specifically authorizes district courts to award enhanced damages if the infringement was "willful or in bad faith"; and requires that patent claims challenged in post-grant administrative proceedings be presumed valid, hence placing the burden on the challenger to prove that claims are invalid. The Act further adds 35 U.S.C. 271(j), which applies to divided infringement, specifically saying "it shall not be a requirement that the steps of the patented process be practiced by a single entity."

8.H.R. 9 at § 5 (amendments to Title 35 of the U.S.C. at § 296)

9.The Wrong Direction on Patents, Roll Call, Mar. 6, 2015, available at http://blogs.rollcall.com/beltway-insiders/the-wrong-direction-on-patents-commentary/?dcz=.

10.President Obama previously expressed a willingness to sign such patent reform legislation in his public support of H.R. 3309. See "Statement of Administration Policy on H.R. 3309" Executive Office of the President. Retrieved 6 December 2013.

11.The only cited evidence of "rampant" patent troll problems is a 2013 report by RPX, a company which provides patent risk management services. See 2013 NPE Litigation Report, available at: http://www.rpxcorp.com/wp-content/uploads/2014/01/RPX-2013-NPE-Litigation-Report.pdf.

12.See supra, footnote 4.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Authors
 
In association with
Related Topics
 
Related Articles
 
Related Video
Up-coming Events Search
Tools
Print
Font Size:
Translation
Channels
Mondaq on Twitter
 
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
 
Email Address
Company Name
Password
Confirm Password
Position
Mondaq Topics -- Select your Interests
 Accounting
 Anti-trust
 Commercial
 Compliance
 Consumer
 Criminal
 Employment
 Energy
 Environment
 Family
 Finance
 Government
 Healthcare
 Immigration
 Insolvency
 Insurance
 International
 IP
 Law Performance
 Law Practice
 Litigation
 Media & IT
 Privacy
 Real Estate
 Strategy
 Tax
 Technology
 Transport
 Wealth Mgt
Regions
Africa
Asia
Asia Pacific
Australasia
Canada
Caribbean
Europe
European Union
Latin America
Middle East
U.K.
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.

Disclaimer

The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.

General

Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions